News Guidelines on treating risk factors turn healthy people into patients, doctors say BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39024.405602.DB (Published 09 November 2006) Cite this as: BMJ 2006;333:988 Article Related content Metrics Responses Peer review Related articles Research Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis Published: 30 March 2011; BMJ 342 doi:10.1136/bmj.d1672 See more Patients with asthma or heart disease should avoid incense sticks and other airborne pollutants, says CMO BMJ June 03, 2025, 389 r1146; DOI: https://doi.org/10.1136/bmj.r1146 Why are UK cardiovascular deaths in under 65s rising again? BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015 Prescribing parkrun: medicalising a walk in the park BMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670 GPs can prescribe tirzepatide to priority patient groups from June BMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665 Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports BMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287 Cited by... Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysisAbstract Fulltext PDF Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular RiskAbstract Fulltext PDF
